Skip to content

Mode of Ventilation and Bleeding During Transsphenoidal Surgery

Transsphenoidal Surgery for Pituitary Adenomas: Influence of the Ventilation Mode on Intraoperative Bleeding

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01891838
Acronym
Vent-Hyp
Enrollment
101
Registered
2013-07-03
Start date
2013-06-30
Completion date
2015-03-31
Last updated
2016-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery

Keywords

surgery, transsphenoidal surgery, pituitary adenoma, mechanical ventilation, bleeding

Brief summary

The risk of bleeding is important during transsphenoidal surgery. This study aims to find if the ventilation mode, controlled pressure and controlled volume, modifies the risk of bleeding.

Detailed description

The risk of bleeding is important during transsphenoidal surgery. This study aims to find if the ventilation mode, controlled pressure and controlled volume, modifies the risk of bleeding. * group Volume controlled ventilation: tidal volume of 7 mL/kg ideal body weight, frequency of 12 cycles/minute, I/E ratio of 1:2, no positive end expiratory pressure. Ventilatory frequency is changed if necessary to maintain end-expiratory pressure of CO2 between 35 and 40 mmHg. * group Pressure-controlled ventilation: initial pressure of 15 cm H2O, frequency of 12 cycles/minute, I/E ratio of 1:2, no positive end expiratory pressure. Pressure is modified to maintain a tidal volume of 7 mL/kg of ideal body weight and frequency ventilation is modified to maintain end-expiratory pressure of CO2 between 35 and 40 mmHg. * In both groups, the fraction of inspired oxygen is 50%. A recruitment maneuver is performed if the blood oxygen saturation became less than 92%.

Interventions

Sponsors

Hopital Foch
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged \> 18 years * Patients scheduled for transsphenoidal surgery for pituitary adenomas

Exclusion criteria

* Pregnancy * Obesity (BMI\> 35) * Known respiratory disease * Redo surgery * Preoperative problem with hemostasis (antiplatelet or anticoagulant treatment; constitutional disorder).

Design outcomes

Primary

MeasureTime frameDescription
intraoperative bleeding1 hour postoperativelyintraoperative bleeding is estimated by the operator (always the same) as minimal (1), low (3), with no significant change in the conduct of the surgical procedure (5) with significant change in the conduct of surgical procedure (7). Intermediate levels are used to rate the levels of intermediate severity.

Secondary

MeasureTime frameDescription
realisation of predefined objectives of minute ventilationone hour after surgerytime spent with the predefined objectives of minute ventilation
changes of ventilation modeone hour after surgerynumber of changes of ventilation mode
arterial desaturationone hour after surgerynumber of episodes of arterial desaturation (SpO2 \<92%) and lower arterial saturation during surgery
generated plateau pressuresone hour after surgerymean ventilatory plateau pressure during surgery
duration of the surgical procedureone hour after surgeryduration from surgical incision to end of the surgical procedure
endocrine healingthree months after surgeryreturn to a low level of the abnormal endocrin abnormalities
recruitment maneuverone hour after surgerynumber of recruitment maneuver

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026